Diabetes Management Device System Market (By Product: Monitoring Devices[ Blood Glucose Meters, Continuous Glucose Monitoring Devices, Self-monitoring Blood Glucose Systems, Test Strips, Lancets, others], Treatment Devices [Insulin Pen, Insulin Pumps, Insulin Jet Injectors, Insulin Syringes, Others]; By Distribution Channel: Institutional Sales, Retail Sales)– Global Industry Analysis, Market Size, Opportunities And Forecast, 2019 - 2026

Table Of Content:

CHAPTER 1. INDUSTRY OVERVIEW
1.1. Definition and Scope
   1.1.1. Definition of Diabetes Management Device System
   1.1.2. Market Segmentation
   1.1.3. List of Abbreviations
1.2. Summary
   1.2.1. Market Snapshot
   1.2.2. Diabetes Management Device System Market By Product
     1.2.2.1. Global Diabetes Management Device System Market Revenue and Growth Rate Comparison By Product (2015-2026)
     1.2.2.2. Global Diabetes Management Device System Market Revenue Share By Product in 2018
     1.2.2.3. Monitoring Devices
       1.2.2.3.1. Blood Glucose Meters
       1.2.2.3.2. Continuous Glucose Monitoring Devices
       1.2.2.3.3. Self-monitoring Blood Glucose Systems
       1.2.2.3.4. Test Strips
       1.2.2.3.5. Lancets
       1.2.2.3.6. others
     1.2.2.4. Treatment Devices
       1.2.2.4.1. Insulin Pen
       1.2.2.4.2. Insulin Pumps
       1.2.2.4.3. Insulin Jet Injectors
       1.2.2.4.4. Insulin Syringes
       1.2.2.4.5. Others
   1.2.3. Diabetes Management Device System Market By Distribution Channel
     1.2.3.1. Global Diabetes Management Device System Market Revenue and Growth Rate Comparison By Distribution Channel (2015-2026)
     1.2.3.2. Global Diabetes Management Device System Market Revenue Share By Distribution Channel in 2018
     1.2.3.3. Institutional Sales
     1.2.3.4. Retail Sales
   1.2.4. Diabetes Management Device System Market By Geography
     1.2.4.1. Global Diabetes Management Device System Market Revenue and Growth Rate Comparison by Geography (2015-2026)
     1.2.4.2. North America Diabetes Management Device System Market Revenue and Growth Rate (2015-2026)
     1.2.4.3. Europe Diabetes Management Device System Market Revenue and Growth Rate (2015-2026)
     1.2.4.4. Asia-Pacific Diabetes Management Device System Market Revenue and Growth Rate (2015-2026)
     1.2.4.5. Latin America Diabetes Management Device System Market Revenue and Growth Rate (2015-2026)
     1.2.4.6. Middle East and Africa (MEA) Diabetes Management Device System Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS
2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
   2.4.1. Bargaining Power of Suppliers
   2.4.2. Bargaining Power of Buyers
   2.4.3. Threat of Substitute
   2.4.4. Threat of New Entrants
   2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
   2.6.1. Raw Material and Suppliers
   2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2018
   2.8.1. Player Positioning Analysis
   2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS
3.1. Capacity and Commercial Production Date of Global Diabetes Management Device System Major Manufacturers in 2018
3.2. Manufacturing Plants Distribution of Global Diabetes Management Device System Major Manufacturers in 2018
3.3. R&D Status and Technology Source of Global Diabetes Management Device System Major Manufacturers in 2018
3.4. Raw Materials Sources Analysis of Global Diabetes Management Device System Major Manufacturers in 2018

CHAPTER 4. DIABETES MANAGEMENT DEVICE SYSTEM MARKET BY PRODUCT
4.1. Global Diabetes Management Device System Revenue By Product
4.2. Monitoring Devices
   4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
   4.2.3. Blood Glucose Meters
   4.2.4. Continuous Glucose Monitoring Devices
   4.2.5. Self-monitoring Blood Glucose Systems
   4.2.6. Test Strips
   4.2.7. Lancets
   4.2.8. others
4.3. Treatment Devices
   4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
   4.3.3. Insulin Pen
   4.3.4. Insulin Pumps
   4.3.5. Insulin Jet Injectors
   4.3.6. Insulin Syringes
   4.3.7. Others

CHAPTER 5. DIABETES MANAGEMENT DEVICE SYSTEM MARKET BY DISTRIBUTION CHANNEL
5.1. Global Diabetes Management Device System Revenue By Distribution Channel
5.2. Institutional Sales
   5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3. Retail Sales
   5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 6. NORTH AMERICA DIABETES MANAGEMENT DEVICE SYSTEM MARKET BY COUNTRY
6.1. North America Diabetes Management Device System Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2. North America Diabetes Management Device System Market Revenue Share Comparison, 2015 & 2026 (%)
6.3. U.S.
   6.3.1. U.S. Diabetes Management Device System Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
   6.3.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
6.4. Canada
   6.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
   6.4.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)

CHAPTER 7. EUROPE DIABETES MANAGEMENT DEVICE SYSTEM MARKET BY COUNTRY
7.1. Europe Diabetes Management Device System Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. Europe Diabetes Management Device System Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. UK
   7.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
   7.3.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
7.4. Germany
   7.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
   7.4.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
7.5. France
   7.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
   7.5.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
7.6. Spain
   7.6.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
   7.6.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
7.7. Rest of Europe
   7.7.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
   7.7.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)

CHAPTER 8. ASIA-PACIFIC DIABETES MANAGEMENT DEVICE SYSTEM MARKET BY COUNTRY
8.1. Asia-Pacific Diabetes Management Device System Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Asia-Pacific Diabetes Management Device System Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. China
   8.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
   8.3.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
8.4. Japan
   8.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
   8.4.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
8.5. India
   8.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
   8.5.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
8.6. Australia
   8.6.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
   8.6.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
8.7. South Korea
   8.7.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
   8.7.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
8.8. Rest of Asia-Pacific
   8.8.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
   8.8.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)

CHAPTER 9. LATIN AMERICA DIABETES MANAGEMENT DEVICE SYSTEM MARKET BY COUNTRY
9.1. Latin America Diabetes Management Device System Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Latin America Diabetes Management Device System Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. Brazil
   9.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
   9.3.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
9.4. Mexico
   9.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
   9.4.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
9.5. Rest of Latin America
   9.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
   9.5.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)

CHAPTER 10. MIDDLE EAST & AFRICA DIABETES MANAGEMENT DEVICE SYSTEM MARKET BY COUNTRY
10.1. Middle East & Africa Diabetes Management Device System Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Middle East & Africa Diabetes Management Device System Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. GCC
   10.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
   10.3.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
10.4. South Africa
   10.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
   10.4.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)
10.5. Rest of Middle East & Africa
   10.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
   10.5.2. Market Revenue and Forecast By Distribution Channel, 2015 - 2026 ($Million)

CHAPTER 11. COMPANY PROFILE
11.1. Abbott
   11.1.1. Company Snapshot
   11.1.2. Overview
   11.1.3. Financial Overview
   11.1.4. Product Portfolio
   11.1.5. Key Developments
   11.1.6. Strategies
11.2. Bayer AG
   11.2.1. Company Snapshot
   11.2.2. Overview
   11.2.3. Financial Overview
   11.2.4. Product Portfolio
   11.2.5. Key Developments
   11.2.6. Strategies
11.3. Becton
   11.3.1. Company Snapshot
   11.3.2. Overview
   11.3.3. Financial Overview
   11.3.4. Product Portfolio
   11.3.5. Key Developments
   11.3.6. Strategies
11.4. Dickinson and Company
   11.4.1. Company Snapshot
   11.4.2. Overview
   11.4.3. Financial Overview
   11.4.4. Product Portfolio
   11.4.5. Key Developments
   11.4.6. Strategies
11.5. Hoffman-La Roche Ltd.
   11.5.1. Company Snapshot
   11.5.2. Overview
   11.5.3. Financial Overview
   11.5.4. Product Portfolio
   11.5.5. Key Developments
   11.5.6. Strategies
11.6. Braun Melsungen AG
   11.6.1. Company Snapshot
   11.6.2. Overview
   11.6.3. Financial Overview
   11.6.4. Product Portfolio
   11.6.5. Key Developments
   11.6.6. Strategies
11.7. PHC Holdings Corporation
   11.7.1. Company Snapshot
   11.7.2. Overview
   11.7.3. Financial Overview
   11.7.4. Product Portfolio
   11.7.5. Key Developments
   11.7.6. Strategies
11.8. Medtronic
   11.8.1. Company Snapshot
   11.8.2. Overview
   11.8.3. Financial Overview
   11.8.4. Product Portfolio
   11.8.5. Key Developments
   11.8.6. Strategies
11.9. Novo Nordisk A/S
   11.9.1. Company Snapshot
   11.9.2. Overview
   11.9.3. Financial Overview
   11.9.4. Product Portfolio
   11.9.5. Key Developments
   11.9.6. Strategies
11.10. Sanofi
   11.10.1. Company Snapshot
   11.10.2. Overview
   11.10.3. Financial Overview
   11.10.4. Product Portfolio
   11.10.5. Key Developments
   11.10.6. Strategies
11.11. Tandem Diabetes Care, Inc.
   11.11.1. Company Snapshot
   11.11.2. Overview
   11.11.3. Financial Overview
   11.11.4. Product Portfolio
   11.11.5. Key Developments
   11.11.6. Strategies
11.12. DexCom, Inc.
   11.12.1. Company Snapshot
   11.12.2. Overview
   11.12.3. Financial Overview
   11.12.4. Product Portfolio
   11.12.5. Key Developments
   11.12.6. Strategies
11.13. Others
   11.13.1. Company Snapshot
   11.13.2. Overview
   11.13.3. Financial Overview
   11.13.4. Product Portfolio
   11.13.5. Key Developments
   11.13.6. Strategies

CHAPTER 12. RESEARCH APPROACH
12.1. Research Methodology
   12.1.1. Initial Data Search
   12.1.2. Secondary Research
   12.1.3. Primary Research
12.2. Assumptions and Scope